Table 1.
Clinical characteristics of 445 cancer patients with malignant pleural effusion undergoing US-guided (group B) and conventional thoracentesis (group A)
|
Group A |
Group B |
P value | |||
|---|---|---|---|---|---|
| N | N | ||||
| |
135 |
30.34% |
310 |
69.66% |
|
| Inpatient/Outpatient (N) |
72/63 |
|
|
84/226 |
0.0001 |
| Male/Female (N) |
75/60 |
177/133 |
0.843 |
||
| Age (mean) (range) |
70.9 (19-87) |
71 (18-88) |
0.916 |
||
| Final diagnosis |
N (%) |
|
|
||
| Lung cancer |
70 (51.86) |
125 (40.32) |
0.031 |
||
| Breast cancer |
56 (41.48) |
119 (38.39) |
0.610 |
||
| Gastrointestinal cancer |
4 (2.96) |
31 (10) |
0.019 |
||
| Other |
5 (3.70) |
35 (11.29) |
0.017 |
||
| Diagnostic thoracentesis |
7 (5.19) |
35 (11.29) |
0.064 |
||
| Therapeutic thoracentesis |
103 (76.30) |
199 (64.19) |
0.016 |
||
| Diagnostic and therapeutic thoracentesis |
25 (18.51) |
76 (24.52) |
0.206 |
||
| Volume of pleural fluid removed (mL) |
|
|
|
||
| Median (range) | 750 40-1,700 | 1100 70-2,300 | 0.447 | ||